Eric L. Dobmeier

2016

In 2016, Eric L. Dobmeier earned a total compensation of $3.7M as Chief Operating Officer at Seattle Genetics, a 65% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$261,800
Option Awards$1,534,003
Salary$453,639
Stock Awards$1,433,700
Other$12,405
Total$3,695,547

Dobmeier received $1.5M in option awards, accounting for 42% of the total pay in 2016.

Dobmeier also received $261.8K in non-equity incentive plan, $453.6K in salary, $1.4M in stock awards and $12.4K in other compensation.

Rankings

In 2016, Eric L. Dobmeier's compensation ranked 2,471st out of 14,075 executives tracked by ExecPay. In other words, Dobmeier earned more than 82.4% of executives.

ClassificationRankingPercentile
All
2,471
out of 14,075
82nd
Division
Manufacturing
850
out of 5,486
85th
Major group
Chemicals And Allied Products
248
out of 1,900
87th
Industry group
Drugs
179
out of 1,543
88th
Industry
Biological Products, Except Diagnostic Substances
38
out of 287
87th
Source: SEC filing on April 5, 2017.

Dobmeier's colleagues

We found six more compensation records of executives who worked with Eric L. Dobmeier at Seattle Genetics in 2016.

2016

Clay Siegall

Seattle Genetics

Chief Executive Officer

2016

Jonathan Drachman

Seattle Genetics

Chief Medical Officer

2016

Vaughn Himes

Seattle Genetics

Chief Technical Officer

2016

Darren Cline

Seattle Genetics

Former Executive Vice President, Commercial

2016

Todd Simpson

Seattle Genetics

Chief Financial Officer

2016

Jean Liu

Seattle Genetics

General Counsel

You may also like